Martin Schüler

机构：German Cancer Research Center, Heidelberg University, National Center for Tumor Diseases, Essen University Hospital, German Marine Research Consortium, West German Heart and Vascular Center Essen, University of Duisburg-Essen · ORCID：0000-0002-2166-3394

发表论文 987 篇 · 总被引 46352 次 · h-index 87

代表论文

• Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial) (2025 · European Heart Journal · 被引 13)
• Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung) (2025 · European Journal of Cancer · 被引 3)
• Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM) (2025 · iScience · 被引 2)
• Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression (2025 · Cells · 被引 2)
• Pretherapeutic prognostic factors for survival under chemoimmunotherapy/immunotherapy of advanced NSCLC patients (2026 · European Journal of Cancer · 被引 1)
• Deep Learning–Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal Cancer (2026 · Clinical Cancer Research · 被引 1)